These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis. Fagugli RM; De Smet R; Buoncristiani U; Lameire N; Vanholder R Am J Kidney Dis; 2002 Aug; 40(2):339-47. PubMed ID: 12148107 [TBL] [Abstract][Full Text] [Related]
23. Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins? Liabeuf S; Glorieux G; Lenglet A; Diouf M; Schepers E; Desjardins L; Choukroun G; Vanholder R; Massy ZA; PLoS One; 2013; 8(6):e67168. PubMed ID: 23826225 [TBL] [Abstract][Full Text] [Related]
24. Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis. Lin CJ; Lin J; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ Kidney Blood Press Res; 2015; 40(2):121-9. PubMed ID: 25833743 [TBL] [Abstract][Full Text] [Related]
25. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study. Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738 [TBL] [Abstract][Full Text] [Related]
26. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease. Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039 [TBL] [Abstract][Full Text] [Related]
27. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure. Lin CJ; Wu V; Wu PC; Wu CJ PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073 [TBL] [Abstract][Full Text] [Related]
28. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients. Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840 [TBL] [Abstract][Full Text] [Related]
29. Increased Levels of Total p-Cresylsulfate Are Associated with Pruritus in Patients with Chronic Kidney Disease. Wang CP; Lu YC; Tsai IT; Tang WH; Hsu CC; Hung WC; Yu TH; Chen SC; Chung FM; Lee YJ; Houng JY Dermatology; 2016; 232(3):363-70. PubMed ID: 27161100 [TBL] [Abstract][Full Text] [Related]
30. Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population. Snauwaert E; Van Biesen W; Raes A; Glorieux G; Van Bogaert V; Van Hoeck K; Coppens M; Roels S; Vande Walle J; Eloot S Nephrol Dial Transplant; 2018 Jun; 33(6):978-986. PubMed ID: 28992139 [TBL] [Abstract][Full Text] [Related]
31. Uremic Toxin Concentrations are Related to Residual Kidney Function in the Pediatric Hemodialysis Population. Snauwaert E; Holvoet E; Van Biesen W; Raes A; Glorieux G; Vande Walle J; Roels S; Vanholder R; Askiti V; Azukaitis K; Bayazit A; Canpolat N; Fischbach M; Godefroid N; Krid S; Litwin M; Obrycki L; Paglialonga F; Ranchin B; Samaille C; Schaefer F; Schmitt CP; Spasojevic B; Stefanidis CJ; Van Dyck M; Van Hoeck K; Collard L; Eloot S; Shroff R Toxins (Basel); 2019 Apr; 11(4):. PubMed ID: 31022857 [TBL] [Abstract][Full Text] [Related]
33. LC-MS/MS method for simultaneous determination of serum p-cresyl sulfate and indoxyl sulfate in patients undergoing peritoneal dialysis. Shu C; Chen X; Xia T; Zhang F; Gao S; Chen W Biomed Chromatogr; 2016 Nov; 30(11):1782-1788. PubMed ID: 27129599 [TBL] [Abstract][Full Text] [Related]
34. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids. Li J; Wang Y; Xu X; Cao W; Shen Z; Wang N; Leng J; Zou N; Shang E; Zhu Z; Guo J; Duan J Phytomedicine; 2019 Apr; 57():166-173. PubMed ID: 30772752 [TBL] [Abstract][Full Text] [Related]
35. Synbiotic meal decreases uremic toxins in hemodialysis individuals: A placebo-controlled trial. Lopes RCSO; Theodoro JMV; da Silva BP; Queiroz VAV; de Castro Moreira ME; Mantovani HC; Hermsdorff HH; Martino HSD Food Res Int; 2019 Feb; 116():241-248. PubMed ID: 30716942 [TBL] [Abstract][Full Text] [Related]
36. Indole-3 acetic acid increased risk of impaired cognitive function in patients receiving hemodialysis. Lin YT; Wu PH; Lee HH; Mubanga M; Chen CS; Kuo MC; Chiu YW; Kuo PL; Hwang SJ Neurotoxicology; 2019 Jul; 73():85-91. PubMed ID: 30826344 [TBL] [Abstract][Full Text] [Related]
37. Removal of protein-bound uraemic toxins by haemodialysis. Niwa T Blood Purif; 2013; 35 Suppl 2():20-5. PubMed ID: 23676831 [TBL] [Abstract][Full Text] [Related]
38. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production. Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217 [TBL] [Abstract][Full Text] [Related]
39. Long term variation of serum levels of uremic toxins in patients treated by post-dilution high volume on-line hemodiafiltration in comparison to standard low-flux bicarbonate dialysis: results from the REDERT study. Panichi V; Rocchetti MT; Scatena A; Rosati A; Migliori M; Pizzarelli F; Gesualdo L; J Nephrol; 2017 Aug; 30(4):583-591. PubMed ID: 28337716 [TBL] [Abstract][Full Text] [Related]
40. The Role of Liver in Determining Serum Colon-Derived Uremic Solutes. Lin CJ; Liou TC; Pan CF; Wu PC; Sun FJ; Liu HL; Chen HH; Wu CJ PLoS One; 2015; 10(8):e0134590. PubMed ID: 26258409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]